These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 31590088

  • 1. 'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings.
    Kolla G, Strike C.
    Int J Drug Policy; 2019 Dec; 74():127-135. PubMed ID: 31590088
    [Abstract] [Full Text] [Related]

  • 2. "I'm not going to lay back and watch somebody die": a qualitative study of how people who use drugs' naloxone experiences are shaped by rural risk environment and overdose education/naloxone distribution intervention.
    Kesich Z, Ibragimov U, Komro K, Lane K, Livingston M, Young A, Cooper HLF.
    Harm Reduct J; 2023 Nov 10; 20(1):166. PubMed ID: 37946233
    [Abstract] [Full Text] [Related]

  • 3. Practices of care among people who buy, use, and sell drugs in community settings.
    Kolla G, Strike C.
    Harm Reduct J; 2020 May 07; 17(1):27. PubMed ID: 32381011
    [Abstract] [Full Text] [Related]

  • 4. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study.
    Doe-Simkins M, Quinn E, Xuan Z, Sorensen-Alawad A, Hackman H, Ozonoff A, Walley AY.
    BMC Public Health; 2014 Apr 01; 14():297. PubMed ID: 24684801
    [Abstract] [Full Text] [Related]

  • 5. Addressing Fear of Negative Consequences of Overdose Response: A Qualitative Study of the Perceptions of Service Industry Workers Who Encounter an Opioid Overdose in an Urban Commercial District in Atlanta, Georgia.
    Febres-Cordero S, Thompson LM, Chalfant OS, Sherman ADF, Winiker AK, Kelly UA, Smith KM.
    Workplace Health Saf; 2024 Jun 01; 72(6):244-252. PubMed ID: 38243156
    [Abstract] [Full Text] [Related]

  • 6. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
    Oliva EM, Christopher MLD, Wells D, Bounthavong M, Harvey M, Himstreet J, Emmendorfer T, Valentino M, Franchi M, Goodman F, Trafton JA, Veterans Health Administration Opioid Overdose Education and Naloxone Distribution National Support and Development Workgroup.
    J Am Pharm Assoc (2003); 2017 Jun 01; 57(2S):S168-S179.e4. PubMed ID: 28292502
    [Abstract] [Full Text] [Related]

  • 7. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
    Lambdin BH, Davis CS, Wheeler E, Tueller S, Kral AH.
    Drug Alcohol Depend; 2018 Jul 01; 188():370-376. PubMed ID: 29776688
    [Abstract] [Full Text] [Related]

  • 8. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
    Strike C, Watson TM.
    Int J Drug Policy; 2019 Sep 01; 71():178-182. PubMed ID: 30975595
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. It's what the community demands: Results of community-based emergency opioid overdose trainings.
    Febres-Cordero S, Smith DJ, Wulkan AZ, Béliveau AJ, Gish A, Zine S, Fugitt L, Giordano NA.
    Public Health Nurs; 2023 Jan 01; 40(1):44-53. PubMed ID: 36377302
    [Abstract] [Full Text] [Related]

  • 11. "I'm not going to lay back and watch somebody die": A qualitative study of how people who use drugs' naloxone experiences are shaped by rural risk environment and naloxone distribution/overdose education intervention.
    Kesich Z, Ibragimov U, Komro K, Lane K, Livingston M, Young A, Cooper H.
    Res Sq; 2023 Sep 06. PubMed ID: 37720025
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs.
    Kim HK, Connors NJ, Mazer-Amirshahi ME.
    Expert Opin Drug Saf; 2019 Jun 06; 18(6):465-475. PubMed ID: 31033357
    [Abstract] [Full Text] [Related]

  • 14. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
    O'Halloran C, Cullen K, Njoroge J, Jessop L, Smith J, Hope V, Ncube F.
    Int J Drug Policy; 2017 Aug 06; 46():34-40. PubMed ID: 28586701
    [Abstract] [Full Text] [Related]

  • 15. Opioid overdose prevention with intranasal naloxone among people who take methadone.
    Walley AY, Doe-Simkins M, Quinn E, Pierce C, Xuan Z, Ozonoff A.
    J Subst Abuse Treat; 2013 Feb 06; 44(2):241-7. PubMed ID: 22980450
    [Abstract] [Full Text] [Related]

  • 16. Addressing Intersecting Housing and Overdose Crises in Vancouver, Canada: Opportunities and Challenges from a Tenant-Led Overdose Response Intervention in Single Room Occupancy Hotels.
    Bardwell G, Fleming T, Collins AB, Boyd J, McNeil R.
    J Urban Health; 2019 Feb 06; 96(1):12-20. PubMed ID: 30073598
    [Abstract] [Full Text] [Related]

  • 17. Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs.
    Oliva EM, Nevedal A, Lewis ET, McCaa MD, Cochran MF, Konicki PE, Davis CS, Wilder C.
    Subst Abus; 2016 Feb 06; 37(1):118-26. PubMed ID: 26675643
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.
    Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A.
    BMJ; 2013 Jan 30; 346():f174. PubMed ID: 23372174
    [Abstract] [Full Text] [Related]

  • 20. Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: Findings from the Take Home Naloxone program.
    Karamouzian M, Kuo M, Crabtree A, Buxton JA.
    Int J Drug Policy; 2019 Sep 30; 71():157-163. PubMed ID: 30691944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.